Related Experiment Video
Updated: Jun 22, 2025

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Microglial Piezo1 mechanosensitive channel as a therapeutic target in Alzheimer's disease
Erol D Ikiz1,2, Erin R Hascup2,3, Chilman Bae4
1Department of Chemistry, School of Integrated Sciences, Sustainability, and Public Health, College of Health, Science, and Technology, University of Illinois at Springfield, Springfield, IL, United States.
Abstract:
Microglia are the resident macrophages of the central nervous system (CNS) that control brain development, maintain neural environments, respond to injuries, and regulate neuroinflammation. Despite their significant impact on various physiological and pathological processes across mammalian biology, there remains a notable gap in our understanding of how microglia perceive and transmit mechanical signals in both normal and diseased states. Recent studies have revealed that microglia possess the ability to detect changes in the mechanical properties of their environment, such as alterations in stiffness or pressure. These changes may occur during development, aging, or in pathological conditions such as trauma or neurodegenerative diseases. This review will discuss microglial Piezo1 mechanosensitive channels as potential therapeutic targets for Alzheimer's disease (AD). The structure, function, and modulation of Piezo1 will be discussed, as well as its role in facilitating microglial clearance of misfolded amyloid-β (Aβ) proteins implicated in the pathology of AD.
Insights
Microglia sense mechanical signals via Piezo1 channels, crucial for brain health and disease. Targeting these channels may offer new Alzheimer's disease therapies by enhancing amyloid-beta clearance.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Microglia, the CNS immune cells, regulate brain development, homeostasis, and neuroinflammation.
- Their ability to sense and respond to mechanical cues in the central nervous system (CNS) is not fully understood.
- Mechanical changes occur during development, aging, and in neurological diseases like Alzheimer's.
Purpose of the Study:
- To review the role of microglial Piezo1 mechanosensitive channels in the CNS.
- To explore Piezo1 as a potential therapeutic target for Alzheimer's disease (AD).
- To discuss Piezo1's function in microglial clearance of amyloid-beta (Aβ).
Main Methods:
- Literature review focusing on microglial mechanosensation and Piezo1 channels.
- Analysis of existing studies on Piezo1 structure, function, and modulation.
- Examination of Piezo1's role in microglial phagocytosis of Aβ.
Main Results:
- Microglia possess Piezo1 channels that detect environmental mechanical stimuli.
- Piezo1 activity influences microglial functions, including phagocytosis.
- Dysfunctional Piezo1 may contribute to AD pathogenesis.
Conclusions:
- Microglial Piezo1 channels are key mediators of mechanotransduction in the CNS.
- Targeting microglial Piezo1 presents a promising therapeutic strategy for Alzheimer's disease.
- Modulating Piezo1 could enhance the clearance of toxic amyloid-beta aggregates.
Related Concept Videos
Mechanically-gated Ion Channels
Alzheimer's Disease: Treatment
Ligand-Gated Ion Channel Receptor: Gating Mechanism

